Stamulumab
Catalog No.
BA9171
Stamulumab (MYO-029) is a recombinant human IgG1λ antibody that binds to muscle growth inhibitor and neutralizes its activity by preventing binding to its endogenous high-affinity receptor, ActRIIB.
Featured Products
Stamulumab (MYO-029) is a recombinant human IgG1λ antibody that binds to muscle growth inhibitor and neutralizes its activity by preventing binding to its endogenous high-affinity receptor, ActRIIB.Stamulumab causes hypertrophy rather than hyperplasia of muscle fibers in SCID mice.Stamulumab has potential for use in Becker muscular dystrophy (BMD), facioscapulohumeral dystrophy (FSHD) and limb-girdle muscular dystrophy (LGMD) studies.
| Physical Appearance | A liquid |
| Storage | -20°C |
| Cas No. | 705287-60-1 |
| Synonyms | MYO-029 |
| Shipping Condition | Small Molecules with Blue Ice, Modified Nucleotides with Dry Ice. |
| General tips | We do not recommend long-term storage for the solution, please use it up soon. |